APPLICATION
NDA012487
TYPE
NDA
ORIGINAL APPROVAL
1962-03-23
LATEST ACTION
1997-06-25
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
TARACTANDiscontinued
CHLORPROTHIXENE 12.5MG/ML · INJECTABLE · INJECTION
Approval history
1997-06-25Labeling · Supplement 25AP
1997-06-25Labeling · Supplement 23AP
1997-06-25Labeling · Supplement 18AP
1997-06-25Labeling · Supplement 24AP
1997-06-25Labeling · Supplement 14AP
1997-06-25Labeling · Supplement 20AP
1984-09-27Labeling · Supplement 21AP
1981-01-29Labeling · Supplement 19AP
1979-01-08Labeling · Supplement 17AP
1974-06-16Labeling · Supplement 12AP
1962-03-23Type 3 - New Dosage Form · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.